Welcome to our dedicated page for RYAN SPECIALTY HOLDINGS SEC filings (Ticker: RYAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ryan Specialty Holdings, Inc. filings document the public-company records of a specialty insurance intermediary with Class A common stock listed on the New York Stock Exchange. Its 8-K reports cover operating and financial results, regular quarterly dividends, share repurchase activity, material agreements involving equity compensation and stock repurchases, and Regulation FD disclosures related to company announcements.
Ryan Specialty proxy and governance filings describe director elections, annual meeting voting results, independent auditor ratification, advisory executive compensation votes, board composition, shareholder proposal procedures, named executive compensation, equity awards and related governance matters. The filings also record director transitions and capital-structure disclosures tied to the company’s incentive plans and shareholder return programs.
Ryan Specialty Holdings director filed a Form 4 reporting a transfer of 2,100 shares of Class A common stock on 12/10/2025. The transaction, coded "G," moved shares at a reported price of $0 per share into trusts for which he serves as trustee and that benefit him and/or family members. After this activity, he beneficially owns 402,795 shares indirectly through the trusts and 256,194.053 shares directly. He states that he disclaims beneficial ownership of the trust-held shares except to the extent of his pecuniary interest in them.
Ryan Specialty Holdings insider Patrick G. Ryan reported a gift of 2,100 shares of Class A common stock on December 10, 2025. The shares were transferred at a price of $0 from insider living trusts where he and his spouse serve as co-trustees, with the gift made equally from each trust. After this transaction, he indirectly holds 13,697,859 Class A shares through these insider living trusts and an additional 55,475 Class A shares held in other trusts and entities for the benefit of a family member. Ryan is listed as a director, 10% owner, and Executive Chairman of the company, and this filing reflects an update to his indirect beneficial ownership.
Ryan Specialty Holdings, Inc. reported that Robert Le Blanc will retire from its Board of Directors effective February 11, 2026. His service on the Compensation and Governance Committee will also end on that date. The company states that his decision to retire is not the result of any disagreement with the company, which signals an orderly and planned transition rather than a dispute-driven departure.
Ryan Specialty expressed gratitude for Mr. Le Blanc’s many years of service and contributions to the Board. On December 8, 2025, the company issued a press release to publicly announce his retirement, which is furnished as an exhibit to this report.
Ryan Specialty Holdings, Inc. (RYAN) reported a large insider sale by a group of reporting persons associated with Onex. On 12/05/2025, they reported the sale of 4,145,621 shares of Class A common stock at a price of $54.5 per share, coded as an open-market or private sale ("S").
After this transaction, the reporting persons show 0 shares of Class A common stock beneficially owned. The filing explains that Onex Corporation controls the entities that previously held the shares and that certain parties, including Onex Corporation and its chairman, disclaim beneficial ownership except for their pecuniary interests. It also notes that, because an Onex executive serves on Ryan Specialty’s board, each reporting person may be considered a director by deputization.
Ryan Specialty Holdings, Inc. had a holder file a notice of intent to sell Class A common stock under Rule 144. The planned sale covers 173,778 shares through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $9,757,634.70 based on the figures provided. The filing notes that 128,776,025 shares of this class were outstanding at the time of the notice, giving context for the size of the proposed sale.
The seller originally acquired 522,119 shares on 07/22/2021 in exchange transactions completed in connection with the company’s IPO, receiving the stock in exchange for interests in a pre-IPO predecessor. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about the company’s operations.
Ryan Specialty Holdings, Inc. has filed a notice of proposed sale under Rule 144 covering Class A common stock. The filing discloses an intention to sell 3,971,843 shares of Class A common stock through J.P. Morgan Securities LLC on the NYSE, with an indicated aggregate market value of $223,018,984.45. The approximate sale date listed is December 5, 2025, and the filing notes that 128,776,025 shares of this class were outstanding.
The securities to be sold trace back to an acquisition on July 22, 2021, in which 11,933,593 shares of Class A common stock were received in exchange transactions connected to the IPO of Ryan Specialty Holdings, Inc., described as an exchange of interests in a pre-IPO predecessor.
Ryan Specialty Holdings reported stronger Q3 results for the quarter ended September 30, 2025. Total revenue rose to $ 754,577 from $ 604,694, driven by higher net commissions and fees of $ 739,552. Operating income increased to $ 110,791 as the company scaled despite higher compensation and benefits and general and administrative expenses. Net income attributable to Ryan Specialty Holdings, Inc. improved to $ 31,085, and diluted EPS was $ 0.20 versus $ 0.09 a year ago.
For the first nine months, revenue reached $ 2,299,913, with operating income of $ 402,078. Net income attributable to the company was $ 55,419 and diluted EPS was $ 0.41. Cash flows from operating activities were $ 380,421, while investing cash flows reflected business combinations of $ ( 636,925 ). The balance sheet showed cash and cash equivalents of $ 153,485, long-term debt of $ 3,349,380, and total stockholders’ equity of $ 1,231,871. Shares outstanding were 263,810,660 as of October 27, 2025, including 128,776,025 Class A and 135,034,635 Class B.
Ryan Specialty Holdings announced two items. The company furnished a press release with results for the third quarter ended September 30, 2025, as Exhibit 99.1. Separately, the board declared a regular quarterly dividend of $0.12 per share on Class A common stock, payable on November 25, 2025 to stockholders of record at the close of business on November 11, 2025.
The results press release was furnished under Item 2.02 and is not deemed filed, and the dividend reflects the board’s ongoing payout on the Class A shares.
Ryan Specialty Holdings, Inc. announced leadership changes in its top executive team. Effective October 9, 2025, the board appointed Stephen P. Keogh as Co-President and Chief Operating Officer and Brendan M. Mulshine as Co-President and Chief Revenue Officer, succeeding Jeremiah Bickham as President.
Keogh, age 59, has been the Company’s Chief Operating Officer since May 2025 and previously held senior leadership roles at Aon plc over more than three decades. Mulshine, also 59, has served as Executive Vice President and Chief Revenue Officer since 2020 after earlier leadership roles at the Company and at Aon Re. The Company states that any changes to their compensation have not yet been determined.
Bickham and the Company agreed that he will transition from his role as President effective October 8, 2025 and serve as a non-employee strategic advisor through January 1, 2026. The filing notes relevant family relationships for Mulshine with the Company’s Founder and a board member and confirms there are no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K.
Ryan Specialty Holdings reported that Michael G. Bungert was appointed to the board by unanimous written consent on September 3, 2025 and began functioning as a director on September 12, 2025. The Form 3 discloses that the reporting person does not beneficially own any securities of the issuer. The filing includes a power of attorney exhibit and was signed by an attorney-in-fact on September 18, 2025.